Newton, MA, United States of America

Peter Suzman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Suzman

Introduction

Peter Suzman is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of medical research, particularly in the area of inflammatory and autoimmune diseases. His work has the potential to impact the treatment of various conditions, including castration-resistant prostate cancer.

Latest Patents

Peter Suzman holds a patent for a method of inhibiting TREM-1. This patent, which is titled "Method of inhibiting TREM-1," discloses methods and uses of the polypharmacological modulator SR1903 and related compounds. These innovations aim to inhibit the triggering receptor expressed on myeloid cells-1 (TREM-1) and address diseases and conditions related to or mediated by TREM-1, such as inflammatory diseases, autoimmune diseases, metabolic disorders, and castration-resistant prostate cancer (CRPC). He has 1 patent to his name.

Career Highlights

Peter Suzman is affiliated with the University of Florida Research Foundation, Incorporated. His role at this esteemed institution allows him to engage in cutting-edge research and development in the medical field. His work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.

Collaborations

Some of his notable coworkers include Patrick Griffin and Mi Ra Chang. Their collaborative efforts contribute to the innovative research environment at the University of Florida Research Foundation.

Conclusion

Peter Suzman is a dedicated inventor whose work in inhibiting TREM-1 has the potential to transform the treatment landscape for various diseases. His contributions to medical research exemplify the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…